Literature DB >> 24958968

Flutamide: hirsutism in women.

Joyce A Generali1, Dennis J Cada2.   

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.

Entities:  

Year:  2014        PMID: 24958968      PMCID: PMC4062730          DOI: 10.1310/hpj4906-517

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  15 in total

1.  Low-dose pioglitazone, flutamide, metformin plus an estro-progestagen for non-obese young women with polycystic ovary syndrome: increasing efficacy and persistent safety over 30 months.

Authors:  Lourdes Ibáñez; Abel López-Bermejo; Marta Díaz; Goya Enríquez; Luis Del Río; Francis De Zegher
Journal:  Gynecol Endocrinol       Date:  2010-05-26       Impact factor: 2.260

Review 2.  Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society.

Authors:  H F Escobar-Morreale; E Carmina; D Dewailly; A Gambineri; F Kelestimur; P Moghetti; M Pugeat; J Qiao; C N Wijeyaratne; S F Witchel; R J Norman
Journal:  Hum Reprod Update       Date:  2011-11-06       Impact factor: 15.610

3.  ACOG Practice Bulletin No. 108: Polycystic ovary syndrome.

Authors: 
Journal:  Obstet Gynecol       Date:  2009-10       Impact factor: 7.661

4.  Retrospective observational study on the effects and tolerability of flutamide in a large population of patients with various kinds of hirsutism over a 15-year period.

Authors:  Roberto Paradisi; Stefano Venturoli
Journal:  Eur J Endocrinol       Date:  2010-04-06       Impact factor: 6.664

5.  Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess.

Authors:  Lourdes Ibáñez; Abel López-Bermejo; Luis del Rio; Goya Enríquez; Carme Valls; Francis de Zegher
Journal:  J Clin Endocrinol Metab       Date:  2007-02-13       Impact factor: 5.958

Review 6.  Acute and fulminant hepatitis induced by flutamide: case series report and review of the literature.

Authors:  Javier Brahm; Magdalena Brahm; Roberto Segovia; Ricardo Latorre; Rodrigo Zapata; Jaime Poniachik; Erwin Buckel; Luis Contreras
Journal:  Ann Hepatol       Date:  2011 Jan-Mar       Impact factor: 2.400

7.  Hepatotoxicity during low-dose flutamide treatment for hirsutism.

Authors:  Camil Castelo-Branco; Marta Del Pino
Journal:  Gynecol Endocrinol       Date:  2009-07       Impact factor: 2.260

8.  The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism.

Authors:  Ebru Dikensoy; Ozcan Balat; Sadrettin Pence; Cenk Akcali; Hulya Cicek
Journal:  Arch Gynecol Obstet       Date:  2008-07-08       Impact factor: 2.344

Review 9.  Clinical review: Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials.

Authors:  Brian A Swiglo; Mihaela Cosma; David N Flynn; David M Kurtz; Matthew L Labella; Rebecca J Mullan; Patricia J Erwin; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-02-05       Impact factor: 5.958

Review 10.  Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline.

Authors:  Kathryn A Martin; R Jeffrey Chang; David A Ehrmann; Lourdes Ibanez; Rogerio A Lobo; Robert L Rosenfield; Jerry Shapiro; Victor M Montori; Brian A Swiglo
Journal:  J Clin Endocrinol Metab       Date:  2008-02-05       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.